S100A8 and neoplasm: Further studies in larger cohorts of ICIs-treated patients are needed in order to proof whether high serum S100A8/A9 and neutrophil counts correlate with neutrophil migration into the tumor tissue, their specific cellular roles in the tumor microenvironment, and their possible use as biomarkers for treatment monitoring.